Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lloyd Sansom

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
BMJ (Clinical Research Ed.)|August 24, 2004
Access to high cost drugs in AustraliaChristine Y Lu, Ken Williams, Ric Day, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?Chris Henshall, Lloyd Sansom, Hans-Georg Eichler, et al.
The Journal of Pediatrics|October 3, 2006
Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trialTaher I Omari, Marc A Benninga, Lloyd Sansom, et al.
Chemosphere|February 13, 2008
Effect of soil ageing on in vivo arsenic bioavailability in two dissimilar soilsAlbert L Juhasz, Euan Smith, John Weber, et al.
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|February 28, 2013
Predicting lead relative bioavailability in peri-urban contaminated soils using in vitro bioaccessibility assaysAlbert L Juhasz, Euan Smith, John Weber, et al.
Chemosphere|June 26, 2007
Comparison of in vivo and in vitro methodologies for the assessment of arsenic bioavailability in contaminated soilsAlbert L Juhasz, Euan Smith, John Weber, et al.
Environmental Geochemistry and Health|December 24, 2008
Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matricesMatthew Rees, Lloyd Sansom, Allan Rofe, et al.
Environmental Science & Technology|December 17, 2009
Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soilsAlbert L Juhasz, John Weber, Euan Smith, et al.
Chemosphere|February 12, 2008
Application of an in vivo swine model for the determination of arsenic bioavailability in contaminated vegetablesAlbert L Juhasz, Euan Smith, John Weber, et al.
Chemosphere|May 29, 2007
In vitro assessment of arsenic bioaccessibility in contaminated (anthropogenic and geogenic) soilsAlbert L Juhasz, Euan Smith, John Weber, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
BMJ (Clinical Research Ed.)|August 24, 2004
Access to high cost drugs in AustraliaChristine Y Lu, Ken Williams, Ric Day, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Understanding the Role and Evidence Expectations of Health Technology Assessment and Coverage/Payer Bodies: What Are They Looking for, and How and Why Does This Differ From What Regulators Require?Chris Henshall, Lloyd Sansom, Hans-Georg Eichler, et al.
The Journal of Pediatrics|October 3, 2006
Effect of baclofen on esophagogastric motility and gastroesophageal reflux in children with gastroesophageal reflux disease: a randomized controlled trialTaher I Omari, Marc A Benninga, Lloyd Sansom, et al.
Chemosphere|February 13, 2008
Effect of soil ageing on in vivo arsenic bioavailability in two dissimilar soilsAlbert L Juhasz, Euan Smith, John Weber, et al.
Journal of Environmental Science and Health. Part A, Toxic/Hazardous Substances & Environmental Engineering|February 28, 2013
Predicting lead relative bioavailability in peri-urban contaminated soils using in vitro bioaccessibility assaysAlbert L Juhasz, Euan Smith, John Weber, et al.
Chemosphere|June 26, 2007
Comparison of in vivo and in vitro methodologies for the assessment of arsenic bioavailability in contaminated soilsAlbert L Juhasz, Euan Smith, John Weber, et al.
Environmental Geochemistry and Health|December 24, 2008
Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matricesMatthew Rees, Lloyd Sansom, Allan Rofe, et al.
Environmental Science & Technology|December 17, 2009
Assessment of four commonly employed in vitro arsenic bioaccessibility assays for predicting in vivo relative arsenic bioavailability in contaminated soilsAlbert L Juhasz, John Weber, Euan Smith, et al.
Chemosphere|February 12, 2008
Application of an in vivo swine model for the determination of arsenic bioavailability in contaminated vegetablesAlbert L Juhasz, Euan Smith, John Weber, et al.
Chemosphere|May 29, 2007
In vitro assessment of arsenic bioaccessibility in contaminated (anthropogenic and geogenic) soilsAlbert L Juhasz, Euan Smith, John Weber, et al.
Pageof 3